Navigation Links
NIH awards Einstein multimillion dollar grant to extend studies of exceptional longevity
Date:9/18/2007

Sept. 17, 2007 -- (BRONX, NY) -- Albert Einstein College of Medicine of Yeshiva University has been awarded a grant of more than $9.25 million from the National Institutes of Health to further the medical schools study of centenarians and the biology of aging.

Led by Dr. Nir Barzilai, director of Einsteins Institute for Aging Research, the research will build on the teams previous work to identify genes that appear to contribute to exceptional longevity in humans, and to assess the associations among these genes with the delay or absence of age-related diseases such as heart attack, stroke, and diabetes. To date, Dr. Barzilai and colleagues have identified several biological markers that, they believe, may have contributed to the health and long lives of the centenarians and their familiesnumbering over 400who have participated in Einsteins Longevity Genes Project.

The NIH grant will support a program of integrated projects, which are aimed at illuminating and expanding the current knowledge of the biological mechanisms of healthy aging. Research goals include:

  • identifying additional genes and genetic variations within genes associated with longevity;

  • identifying the ways these genes and their variants interact in humans;

  • identifying the specific mechanisms of these genes and their variants, as well as their roles in the onset or absence of age-related diseases and/or mental and physical preservation;

  • examining whether these longevity genes are likely to affect the incidence of cardiovascular disease and other life-threatening illnesses in the offspring of centenarians; and

  • examining whether these longevity genes affect the incidence of cognitive impairment in relation to the presence of favorable genotypes and their phenotypic expression.

We are very grateful to the NIH for its support, said Dr. Barzilai, who also is the Ingeborg
'/>"/>

Contact: Karen Gardner
kgardner@aecom.yu.edu
718-430-3101
Albert Einstein College of Medicine
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Aussie Nobel Prize Winners Receive Their Awards
2. Prestigious Gairdner Awards for medical research in 2006 Goes To Two Yale biologists
3. The President Gives Away National Disability Awards
4. Majority of Padma Awards Go to Doctors from Delhi
5. US, Indian Doctors Bag Thai Medical Awards
6. WHO Awards Prequalification Status to the First UAE Approved Vaccine
7. Bio-Rad Gets Life Science Industry Awards – 200
8. Michael J. Fox Foundation Awards $710,000 to Understanding of Parkinsons Disease Subtypes
9. Ontario Court Awards Compensation To Paralyzed Worker
10. Talwalkars Awards a Record $1 Million Order to Nautilus
11. NIH Awards Emory $3.6 Million for Schizophrenia Gene Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2008)...alth-related Questions for Tonight,s,Presidential ...- WebMD, the leading source of,health information,...ial,candidates, proposed health care policies, loc...t the candidates, stance on health insurance, medi... public health issues., The in-depth coverage is ...
(Date:10/7/2008)...PRNewswire-USNewswire/ -- The Ohio Nurses,Associat...ced today its,final round of endorsed candidates f...o Senate:, SD 26 Karen Gillmor (R) Tiffin, Ohio ...(R) Grove City;, HD 28 Connie Pillich (D) Cincinn...These ONA-endorsed candidates for the Ohio General...
(Date:10/7/2008)...wswire-USNewswire/ -- Kristi Yamaguchi, Olympic,Go... the Stars, has been,named chairperson for the 200...gn in an effort to help raise funds in support of ...e and promote lung health., The American Lung Ass...o conquer Tuberculosis. Today, the Lung Associatio...
(Date:10/7/2008)...ar to more expensive whole-leg color ultrasound, ...lthDay News) -- An older, simpler test to look for...osis, or DVT -- is as effective as a newer, more e...searchers found that 2-point ultrasonography of th...trasound -- was as good at detecting DVT as the ne...
Breaking Medicine News(10 mins):Health News:WebMD Highlights Presidential Candidates' Views on Health Care 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 3Health News:Kristi Yamaguchi Chairs American Lung Association Christmas Seals Campaign 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 3
...A new immunosuppression regimen for heart transpla...t transplant coronary artery disease//, according ...ill report their findings on April 26 at The Inter...splantation Annual Meeting and Scientific Session ...
...An international research team, led by investigato...ancer Center and Dana-Farber Cancer Institute (DFC...come resistant to treatment with targeted therapy ...ch will appear in the journal Science and is recei...
...Results of a Japanese study have given drug gian... the study published in The Lancet, the company’s ...e the risks of strokes and cardiovascular events b...e Jikei Heart Study, was based on 3,000 people age...
...A simple scoring system based on five medical fact...dered for gastric bypass surgery would be at highe... first proposed last year by Duke University Medic... in a new study of more than 4,400 patients. The s...
Other Medicine News:Health News:Mayo Clinic Study Finds Heart Transplant Patients Benefit from New Approach to Immunosuppression 2Health News:New Mechanism Identified for Resistance to Targeted Lung Cancer Drugs 2Health News:New Mechanism Identified for Resistance to Targeted Lung Cancer Drugs 3Health News:Novartis Drug Diovan Shows Superior Benefits 2Health News:Simple System Accurately Predicts Weight-loss Surgery Risk 2Health News:Simple System Accurately Predicts Weight-loss Surgery Risk 3
(Date:10/7/2008)...Stage A of Trial Assessing Regimen of Bavituxim...-, TUSTIN, Calif., Oct. 7 /PRNewswire-FirstCall/ ...), a clinical stage biopharmaceutical,company deve...cancer and,hepatitis C virus (HCV) infection, toda...e first stage of a Phase II trial of bavituximab i...
(Date:10/6/2008)...irstCall/ -- Pharmasset, Inc.,(Nasdaq: VRUS ) ann...the,Company as Vice President of Investor Relation...responsible for all investor relations,functions a... Kurt,Leutzinger., Most recently, Dr. Smith was a...t JPMorgan Securities, and has been an analyst in ...
(Date:10/6/2008)... Scientific Conference -, ORLANDO, Fla., Oct. 6 /...Microbia) today announced presentation of data fro...le that cyclic guanosine,monophosphate (cGMP) play...monstrate that cGMP inhibits intestinal pain in a ...esensitizes colonic afferent nerves in a,similar m...
(Date:10/6/2008)...urezol Dosed Prior to Surgery, TAMPA, Fla., Oct. ...vately held ophthalmic-focused biopharmaceutical c...dnate ophthalmic emulsion) 0.05% is now,commercial....S. Food and,Drug Administration in June 2008, is ...the treatment of inflammation and pain associated ...
Breaking Medicine Technology:Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 2Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 3Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 4Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications 2Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications 3Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain 2Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain 3Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 2Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 3Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 4Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 5New leukemia signal could point way to better treatment Stanford researchers find 26527 1New leukemia signal could point way to better treatment Stanford researchers find 26527 2 Caterpillar Logistics Services Retirees Win a Preliminary Injunction Providing Them Premium Free Retiree Healthcare 26525 1 Caterpillar Logistics Services Retirees Win a Preliminary Injunction Providing Them Premium Free Retiree Healthcare 26525 2 Caterpillar Logistics Services Retirees Win a Preliminary Injunction Providing Them Premium Free Retiree Healthcare 26525 3NJHA 3A Hospitals Achieve Gains in Healthcare Quality But Commitment to Improve Continues 26522 1NJHA 3A Hospitals Achieve Gains in Healthcare Quality But Commitment to Improve Continues 26522 2Message to North Carolina Residents 3A Forgo Fad Dieting and Join the Campaign for Healthy Weight 26519 1Message to North Carolina Residents 3A Forgo Fad Dieting and Join the Campaign for Healthy Weight 26519 2Message to North Carolina Residents 3A Forgo Fad Dieting and Join the Campaign for Healthy Weight 26519 3
...d,today announced results from a study published i...that suggest infusions of a novel,new drug, CSL-11...terol) levels, may reduce the amount of plaque in ...isode of acute,coronary syndrome (ACS). , CSL advi...sclerosis – Safety and Efficacy (ERASE) tria...
...Interleukin,Genetics, Inc. (AMEX:ILI) and collabor...day reported at the American College of,Cardiology... artery,disease (CAD) and both oxidized phospholip... on pro-inflammatory variants of the,interleukin-1...uence of Oxidized,Phospholipids and Lp(a) Lipoprot...
Other Medicine Technology:CSL Therapy That Mimics “Good” Cholesterol May Reduce,Plaque Volume in Coronary Arteries 2CSL Therapy That Mimics “Good” Cholesterol May Reduce,Plaque Volume in Coronary Arteries 3ACC Presentation Indicates Interleukin-1 Gene Variants Determine,Increased Risk for Coronary Artery Disease from Oxidized,Phospholipids 2ACC Presentation Indicates Interleukin-1 Gene Variants Determine,Increased Risk for Coronary Artery Disease from Oxidized,Phospholipids 3
Basic-level interpretive resting ECG
Mid-level interpretive resting ECG
Cruise Control is a device developed by STAAR as a filter between the phaco handpiece and aspiration tubing that captures nuclear material, enhances the safety and efficiency of phaco procedures by e
...rovides the ultimate flexibility for performing sl... a patient room or in the sleep laboratory. Travel...an VISION analysis software as your in-lab studies...f many powerful Sleepscan features such as the VIS...
Medicine Products: